Latest KFF Health News Content

Latest KFF Health News Stories

Emails From Purdue Pharma Reveal Just How Aggressively Richard Sackler Pushed Back Against Addiction Warnings

Morning Briefing

Following a years-long court battle, Stat obtained documents from the early days of the opioid crisis that reveal what was going on behind the scenes at OxyContin-maker Purdue Pharma. Meanwhile, in other news from the opioid crisis: advocates worry stigma over drug use will stand in the way of compensation for those who have been harmed; pain doctors stay busy during the epidemic; drugs in schools; and meth.

Bipartisan Group Of Lawmakers Slam Trump’s Decision To Back Off Flavor Ban: ‘Our Children Should Not Be Used As Guinea Pigs’

Morning Briefing

“I’m very disappointed that industry was able to elbow its way into the discussion and hold up the ban,” said Rep. Raja Krishnamoorthi (D-Ill.) of reports that the vaping industry influenced President Donald Trump’s retreat on the issue. “Our children are not for sale.” In other vaping news: life insurance, a rise in arrests across U.S., and taxes.

Could Supreme Court’s First Major Gun Case In Nearly A Decade Be Dismissed As Moot?

Morning Briefing

Although the case is being closely watched, much of the arguments focus on whether the court should even decide the merits of the legal challenge because New York City eliminated the limits that are central to the case.

Lawmakers, Medical Groups, Lawyers Urge Supreme Court To Block Strict Louisiana Abortion Law

Morning Briefing

The Supreme Court is scheduled to hear oral arguments in March on the state’s new requirements around abortion providers’ admitting privileges to hospitals. “Laws regulating abortion should be evidence-based and supported by a valid medical justification,” the medical groups wrote to the court. A similar Texas law was ruled unconstitutional, put the political make-up of the high court has shifted since that decision.

State Lawmakers’ Op-Eds Provide Glimpse Inside Lobbying Machine Working Against ‘Medicare For All’

Morning Briefing

The revelation that lobbyists helped draft or made edits to the lawmakers’ opinion pieces shows that critics of “Medicare for All” are investing time and energy beyond the presidential debate over the policy issue.

Moderate Dems Are Touting Less Extreme ‘Public Option.’ But Even That Could Be Earthquake For Industry.

Morning Briefing

The public option, of course, would be less disruptive than getting rid of private insurance all together, but an inexpensive and attractive plan could still shake up the industry landscape. Meanwhile, former Vice President Joe Biden says 2020 rival Pete Buttigieg “stole” his health care plan.

Hidden Dangers Of Dating Apps: Sex Offenders, Including Rapists, Are Using Them. Why Do Companies Allow It?

Morning Briefing

A lack of a uniform policy allows convicted and accused perpetrators to access some dating apps and leaves users vulnerable to sexual assaults, according to an investigation. Public health news is on stem cell heart therapy, flu season, Parkinson’s disease, poetry therapy, problems with blood-sugar monitors, warnings about ski helmets, a grateful transplant patient, children prone to violent outbursts, and more.

As Schools Move To Crack Down On Vaping, A New Problem Arises: Litter In The Shape Of Discarded Pods

Morning Briefing

The extent of the trash reveals “how much this has become a part of our students’ lives,” says Kristen Lewis, an assistant principal in Boulder, Colo. “And that’s what’s scary… It really has become an epidemic in our schools.” News on the vaping epidemic focuses on a flavor ban, political fallout, doctors’ efforts to warn teens of e-cigarette hazards, and more.

In Their Own Words: High School Class Of 2000 Alums Talk About What It Was Like To Be At Heart Of Opioid Epidemic

Morning Briefing

As the class of 2000 headed toward graduation, an opioid epidemic was cropping up and spreading like wildfire. Nearly two decades later, the students who were there at the beginning of the epidemic recount just how much it has affected their lives. In other news on the crisis: safe injections of heroin, how a counterterroism machine helps fight overdoses, the end of the era of pill mills, and more.

Inexpensive, Tasty Medicine From Indian Drug Manufacturer Is ‘Great News’ For Thousands of Babies Born With HIV

Morning Briefing

For only $1 a day, early deaths can be prevented among toddlers whose mothers find the strawberry-flavored meds easier to dispense. News on HIV among infants is on the importance of starting treatment right after birth, as well.

Drugmakers Betting Big On Gene Therapy By Investing Combined $2B Into Manufacturing Pricey Treatments

Morning Briefing

And Pfizer and Novartis are leading the pack. The risks involved with drugmakers building their own manufacturing plants are big but so are the potential rewards. In other pharmaceutical news: a high-stakes bet on heart drugs, an invite-only club for biotech CEOs, President Donald Trump’s importation plan, and more.